Efficacy of a New Protocol of Premixed 70/30 Human Insulin in Haitian Youth with Diabetes

被引:2
|
作者
Jean-Baptiste, Eddy [1 ]
Larco, Philippe [1 ]
von Oettingen, Julia [2 ,3 ]
Ogle, Graham David [4 ]
Moise, Keddy [1 ]
Fleury-Milfort, Evelyne [1 ]
Paul, Rodolphe [1 ]
Charles, Rene [1 ]
Larco, Nancy Charles [1 ]
机构
[1] Haitian Fdn Diabet & Cardiovasc Dis FHADIMAC, 208 Lalue, HT-6114 Port Au Prince, Haiti
[2] McGill Univ Hlth Ctr, Res Inst, 1650 Cedar Ave, Montreal, PQ H3G 1A3, Canada
[3] Montreal Childrens Hosp, 1001 Blvd Decarie, Montreal, PQ H4A 3J1, Canada
[4] Diabet NSW, Life Child Program, 26 Arundel St, Glebe, NSW 2037, Australia
关键词
Insulin-treated diabetes; Low-resource setting; Missed self-monitoring of blood glucose tests; Premixed insulin; Self-management education; Self-mixed insulin; Skipped meals; Sliding scales; Youth-onset diabetes; DISPARITIES; MANAGEMENT; CHILDREN;
D O I
10.1007/s13300-021-01130-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Controlling insulin-treated diabetes is challenging in low-resource settings where only Neutral Protamine Hagedorn (NPH), regular (R) and premixed insulin formulations are available, self-monitoring of blood glucose (SMBG) supplies are scarce and food insecurity is common. We examined the impact of a treatment protocol that includes sliding scale-based 70/30 insulin adjustments in Haiti. Methods Thirty young patients aged 11-28 years with diabetes treated with premixed 70/30 insulin twice daily were included in the study. The participants performed one or two daily self-monitoring of blood glucose (SMBG) tests and attended our diabetes clinic monthly. They were randomized to two treatment groups, with one group remaining on the 70/30 insulin formulation (group 70 [G70]) and the other group switching to self-mixed NPH + R (group NR [GNR]). Sliding scales for insulin correction doses and meal insulin doses were designed based on the total daily insulin dose (TDD), carbohydrate ratio and insulin sensitivity factor. SMBG tests and insulin were administered before the morning and evening meals. The frequency of visits to the diabetes clinic was increased to biweekly during a 14-week follow-up. Results Fifteen patients of each group were included in the analysis. Baseline characteristics, increase in total daily dose and number of missed SMBG tests and skipped meals at 14 weeks did not differ between the two groups. Hemoglobin A1c (HbA1c) decreased from 9.5% (interquartile range [IQR] 8.8, 10.5) (80.3 mmol/mol) to 8.0% (IQR 7.1%, 9.0%) (63.9 mmol/mol) in G70 (p = 0.01), and from 10.6% (IQR 8.1,% 13.1)% (92.4 mmol/mol) to 9.0% (IQR 7.6%, 9.6%) (74.9 mmol/mol) in GNR (p = 0.10), with no significant between-group difference in reductions (p = 0.12). No serious acute complications were reported. Stopping the use of sliding scales and resuming monthly visits increased HbA1c to values not significantly different from baseline in both groups after 15 weeks. Conclusion The use of sliding scales adjusted for missed SMBG tests and skipped meals, and frequent clinic visits that focus on patient self-management education significantly improved glycemic control in the patients with youth-onset diabetes in our study treated with premixed 70/30 human insulin in a low-resource setting.
引用
收藏
页码:2545 / 2556
页数:12
相关论文
共 50 条
  • [31] Efficacy, Safety, and Immunogenicity of Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Compared with Originator Insulin Aspart Mix 70/30 in Adults with Diabetes (GEMELLI M): A Subgroup Analysis by Prior Type of Premix Insulin
    S. R. Aravind
    Kiran P. Singh
    Liliia Mogylnytska
    Alsu G. Zalevskaya
    Beata Matyjaszek-Matuszek
    Karin Wernicke-Panten
    My-Liên Nguyên-Pascal
    Suzanne Pierre
    Baerbel Rotthaeuser
    Daniel Kramer
    Bhaswati Mukherjee
    [J]. Diabetes Therapy, 2022, 13 : 1299 - 1310
  • [32] Efficacy, Safety, and Immunogenicity of Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Compared with Originator Insulin Aspart Mix 70/30 in Adults with Diabetes (GEMELLI M): A Subgroup Analysis by Prior Type of Premix Insulin
    Aravind, S. R.
    Singh, Kiran P.
    Mogylnytska, Liliia
    Zalevskaya, Alsu G.
    Matyjaszek-Matuszek, Beata
    Wernicke-Panten, Karin
    Nguyen-Pascal, My-Lien
    Pierre, Suzanne
    Rotthaeuser, Baerbel
    Kramer, Daniel
    Mukherjee, Bhaswati
    [J]. DIABETES THERAPY, 2022, 13 (07) : 1299 - 1310
  • [33] Efficacy and safety of biphasic insulin aspart 70/30 in type 2 diabetes patients of different race or ethnicity (INITIATEplus trial)
    Trippe, Bruce S.
    Shepherd, Mark D.
    Coulter, Franklin C.
    Bhargava, Anuj
    Brett, Jason
    Chu, Pei-Ling
    Oyer, David S.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (07) : 1203 - 1211
  • [34] Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
    Valensi, Paul
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY, 2009, 2 : 61 - 71
  • [35] Post-challenge glucose responses to fixed mixtures of insulin lispro, human insulin 30/70, and insulin glargine in patients with Type 2 diabetes.
    Schwartz, S
    Zagar, A
    Althouse, S
    Pinaire, JA
    Holcombe, JH
    [J]. DIABETOLOGIA, 2003, 46 : A267 - A268
  • [36] Efficacy and safety of premixed insulin analogs in Asian patients with type 2 diabetes: A systematic review
    Sheu, Wayne H-H
    Ji, Linong
    Lee, Woo Je
    Jabbar, Abdul
    Han, Jeong Hee
    Lew, Thomas
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2017, 8 (04) : 518 - 534
  • [37] ACTION OF A SEMI-SYNTHETIC HUMAN INSULIN PREPARATION (30/70 NPH INSULIN ORGANON) - COMPARISON WITH ANOTHER 30/70 NPH (ACTRAPHANE NOVO)
    GIN, H
    NIVET, AM
    MORLAT, P
    AUBERTIN, J
    [J]. DIABETES & METABOLISM, 1989, 15 (05): : 247 - 250
  • [38] Efficacy of biphasic insulin aspart 70/30 in insulin-naive patients with type 2 diabetes mellitus not achieving glycemic targets on oral antidiabetic agents
    Garber, Alan J.
    Jain, Rajeev
    Wahl, Timothy
    Moses, Alan
    Cao, Anjun
    Bressler, Peter
    [J]. DIABETES, 2006, 55 : A477 - A477
  • [39] Pharmacokinetic and pharmacodynamic advantages of insulin analogues and premixed insulin analogues over human insulins: Impact on efficacy and safety
    Rolla, Arturo
    [J]. AMERICAN JOURNAL OF MEDICINE, 2008, 121 (06): : 9 - 19
  • [40] Insulin aspart in pregnancy: Protocol for a randomized controlled trial comparing the safety and efficacy of insulin aspart and human insulin in the treatment of pregnant women with type 1 diabetes
    Hod, M
    Amiel, S
    Damm, P
    Dunne, F
    Heller, S
    Lertoft, B
    Mathiesen, E
    Mccance, D
    Visser, G
    [J]. DIABETES, 2003, 52 : A567 - A567